Literature DB >> 21491119

[Gingival hyperplasia and visual reduction].

M Haustein1, J Babatz, F Sommer, J Radke, C Hoffmann, L E Pillunat, D Sandner.   

Abstract

This case report describes the unilateral acute reduction of vision in the right eye of a 48-year-old woman. The patient was otherwise healthy but 2 days previously had suffered from dizziness and blurred vision. Secondary to this, the patient had already been under dental treatment for 1 week due to gingival swelling. At the first examination a macular branch retinal vein occlusion and Roth spots were found in the right eye by indirect ophthalmoscopy. The immediate diagnostic procedure identified aute amyeloid leukemia (AML) as the cause of the vascular pathology. The AML can be manifested in different ways and the retina is involved in approximately 50% of cases. Due to a secondary hyperviscosity syndrome, which is found in approx. 20% of acute leukaemias, symptomatic central vein occlusion or macular branch vein occlusion can occur. Ophthalmic symptoms can be the first and only signs to be detected. Therefore, ophthalmologists should also consider a systemic disease and initiate a clarification. A differential blood count is indispensable. The results usually improve by a rapidly arranged and suitable therapy. Ophthalmological follow-up examinations are imperative as an initiated chemotherapy can also produce ophthalmological side-effects.

Entities:  

Mesh:

Year:  2011        PMID: 21491119     DOI: 10.1007/s00347-011-2352-7

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  15 in total

Review 1.  [Diagnostics and therapy of acute myeloid leukemia].

Authors:  M Bornhäuser; G Ehninger
Journal:  Dtsch Med Wochenschr       Date:  2009-09-16       Impact factor: 0.628

2.  [The characteristics of macular branch retinal vein occlusion].

Authors:  H Zhang; W An; J Lei
Journal:  Zhonghua Yan Ke Za Zhi       Date:  1996-11

Review 3.  Central retinal vein occlusion: review of management.

Authors:  N Bhagat; M F Goldberg; P Gascon; W Bell; J Haberman; M A Zarbin
Journal:  Eur J Ophthalmol       Date:  1999 Jul-Sep       Impact factor: 2.597

4.  Ophthalmic manifestations of leukemia.

Authors:  A P Schachat; J A Markowitz; D R Guyer; P J Burke; J E Karp; M L Graham
Journal:  Arch Ophthalmol       Date:  1989-05

5.  Prognostic significance of retinopathy at presentation in adult acute leukemia.

Authors:  S C Reddy; S H Quah; H C Low; N Jackson
Journal:  Ann Hematol       Date:  1998-01       Impact factor: 3.673

6.  Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412.

Authors:  Ellen Weisberg; Christina Boulton; Louise M Kelly; Paul Manley; Doriano Fabbro; Thomas Meyer; D Gary Gilliland; James D Griffin
Journal:  Cancer Cell       Date:  2002-06       Impact factor: 31.743

Review 7.  [Retinal vein occlusions].

Authors:  S Dithmar; L L Hansen; F G Holz
Journal:  Ophthalmologe       Date:  2003-07       Impact factor: 1.059

Review 8.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

9.  Systemic diseases associated with various types of retinal vein occlusion.

Authors:  S S Hayreh; B Zimmerman; M J McCarthy; P Podhajsky
Journal:  Am J Ophthalmol       Date:  2001-01       Impact factor: 5.258

10.  Association of monocytic leukemia in patients with extreme leukocytosis.

Authors:  J Cuttner; M S Conjalka; M Reilly; J Goldberg; A Reisman; R J Meyer; J F Holland
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

View more
  1 in total

1.  Unilateral macular choroidal neovascularization-a rare manifestation in acute myelocytic leukemia: Case report.

Authors:  Xiaochun Yang; Jianbiao Xu; Jianhui Yang; Yikun Zhou; Yan Mei; Tonghua Yang; Yangmo Zhang
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.